322 related articles for article (PubMed ID: 34379859)
1. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
[TBL] [Abstract][Full Text] [Related]
2. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
Khan F; Rahman A; Tritschler T; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Pinede L; Parpia S; Geersing GJ; Takada T; Bradbury CA; Andreozzi GM; Palareti G; Prandoni P; Buller HR; Mallick R; Hutton B; Thavorn K; Le Gal G; Rodger MA; Fergusson DA
Thromb Haemost; 2022 Jul; 122(7):1186-1197. PubMed ID: 34753191
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Thavorn K; Hutton B; Le Gal G; Fergusson DA; Rodger MA;
Ann Intern Med; 2021 Oct; 174(10):1420-1429. PubMed ID: 34516270
[TBL] [Abstract][Full Text] [Related]
6. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
[TBL] [Abstract][Full Text] [Related]
7. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
8. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
9. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
Khan F; Coyle D; Thavorn K; van Katwyk S; Tritschler T; Hutton B; Le Gal G; Rodger MA; Fergusson DA
Ann Intern Med; 2023 Jul; 176(7):949-960. PubMed ID: 37364263
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
12. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
13. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
[TBL] [Abstract][Full Text] [Related]
15. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
[TBL] [Abstract][Full Text] [Related]
16. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review.
van der Wall SJ; van der Pol LM; Ende-Verhaar YM; Cannegieter SC; Schulman S; Prandoni P; Rodger M; Huisman MV; Klok FA
Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30487292
[TBL] [Abstract][Full Text] [Related]
17. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
18. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
19. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Carrier M; Le Gal G; Wells PS; Rodger MA
Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]